Research study Program year 2025 Source: CMS Open Payments

Gantenerumab in Early Ad

Research payments

$49,220,821

2,482 payments

Through program year 2025, $49,220,821 in research payments was reported against Gantenerumab in Early Ad, across 2,482 payments.

Paid by (largest first): Genentech, Inc.; F. Hoffmann-La Roche AG
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$520	1
2024	Research	$171,651	14
2023	Research	$567,016	68
2022	Research	$4,668,979	278
2021	Research	$13,938,421	621
2020	Research	$17,711,977	741
2019	Research	$12,162,257	759

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $49,220,184 2,481 payments
F. Hoffmann-La Roche AG $637 1 payment

Who received the money Research payments · program years 2019–2025

Alzheimers Research And Treatment Center Organisation paid for research $6,351,008 91 payments
Optimus U Corp Organisation paid for research $3,424,438 42 payments
Center For Advanced Research & Organisation paid for research $3,017,484 97 payments
Elias Research Associates LLC Organisation paid for research $1,665,281 30 payments
Clincloud Llc Organisation paid for research $1,548,768 82 payments
Renstar Llc Renstar Medical Research Organisation paid for research $1,467,518 72 payments
Sentara Hospital Billing Office Organisation paid for research $1,382,101 14 payments
Research Center For Clinical Studies INC Organisation paid for research $1,195,449 42 payments
Washington University Organisation paid for research $1,144,196 42 payments
Advanced Memory Research Institute Of Nj Pc Organisation paid for research $1,099,716 30 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.